Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
A new HIV vaccine prompts powerful antibody response in animals.
Research in human cells and mice found the antiretroviral suppressed harmful chronic inflammation linked to age-related disorders.
Researchers have devised a means of injecting an antiretroviral under the skin that hardens into a dissolvable and removable implant.
Researchers have found a way of stabilizing a shape-shifting viral protein so as to promote a greater antibody response.
NIH researchers have prompted animals to develop broadly neutralizing antibodies against the virus; an early human trial is in the works.
The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
For the first time, scientists have used the powerful, cutting-edge CRISPR/Cas9 gene-editing method to snip HIV out of infected mice.
The feat marks an important milestone in the mammoth effort to find a cure for HIV.
Researchers significantly reduced HIV levels in mice with a genetic therapy that prompts immune cells to better fight the virus.
Researchers significantly reduced HIV levels in mice with a genetic therapy that induces immune cells to better fight the virus.
Research conducted in mice supports a previous petri dish study’s finding that cocaine causes a physiological susceptibility to HIV infection,...
A study conducted in mice has shown that a toxin engineered to target HIV can eliminate infected immune cells.
Engineering immune cells to produce “broadly neutralizing antibodies” protects mice with human immune systems against HIV infectio...
In a mouse study, a toxin engineered to target HIV eliminated infected immune cells in which the virus was replicating despite antiretroviral...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.